Monthly Archives: November 2018

Parkinson’s therapy creates new brain circuits for motor function, study finds

Posted

MANHASSET, NY – Scientists have uncovered that an emerging gene therapy for Parkinson’s disease creates new circuits in the brain associated with improved motor movement. These findings, published today in Science Translational Medicine by Feinstein Institute for Medical Research Professor David Eidelberg, MD, and his team, explain the therapeutic mechanisms involved in the emerging Parkinson’s gene… read more

posted in: Press Releases

NIH $1.4M grant supports study into precision bioelectronic medicine

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Professor Larry Miller, MD, has received a one-year, $1.4 million grant from the National Institutes of Health (NIH) to develop and test a non-invasive method that accesses nerves in the chest and abdomen. Gaining non-invasive access to these nerves has the potential to drive development of bioelectronic medicine… read more

posted in: Press Releases

Researchers eye mental health impacts of Hurricane Harvey

Posted

SAN DIEGO, CA – Recent research shows that exposure to natural disasters such as Hurricane Harvey are associated with increased stress and anxiety – data that will be used to better understand the mental health impact of future storms. These findings may help local officials and relief organizations better prepare to offer adequate care in the… read more

posted in: Press Releases

Scientist recognized for dystonia research by The Michael J. Fox Foundation

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Professor David Eidelberg, MD, won the fourth annual Bachmann-Strauss Prize for Excellence in Dystonia Research. Dr. Eidelberg received an unrestricted $100,000 grant for his use of innovative brain imaging techniques and computational algorithms to better understand the pathophysiology of this disorder and its treatment. Michael J. Fox and… read more

posted in: Press Releases

Researchers use genetics to predict response to antipsychotic medications

Posted

MANHASSET, NY – Genetics can be used to predict a patient’s response to antipsychotic drug treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online today in the American Journal of Psychiatry. Schizophrenia is one of the leading causes of disability in the U.S…. read more

posted in: Press Releases

Multiple sclerosis scientist discusses latest research at Feinstein Institute Marsh Lecture

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research hosted a Marsh Lecture by Stanford University George A. Zimmerman Professor and Professor of Pediatrics Lawrence Steinman, MD. Dr. Steinman discussed his research into the role amyloid proteins play in slowing immune response in patients with multiple sclerosis (MS). Amyloid proteins are often thought to be the… read more

posted in: Press Releases